Hyperoxic Condition Promotes an Inflammatory Response During Cardiopulmonary Bypass in a Rat Model

Artificial Organs

Volumn 37, Issue 12, 2013, Pages 1034-1040

  Fujii, Yutaka ^a,b   Shirai, Mikiyasu ^a   Tsuchimochi, Hirotsugu ^a   Pearson, James T ^c   Takewa, Yoshiaki ^a   Tatsumi, Eisuke ^a   Taenaka, Yoshiyuki ^a,b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Cardiopulmonary bypass model; Cytokine; Hyperoxia; Superoxide; Systemic inflammation

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; BIOLOGICAL ORGANS; BLOOD PRESSURE; MERCURY COMPOUNDS; OXYGEN;

BIOCHEMICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS MODEL; CONDITION; CYTOKINES; HYPEROXIA; INFLAMMATORY RESPONSE; RAT MODEL; SUPEROXIDES; SYSTEMIC INFLAMMATION;

RATS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HYDROETHIDINE; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BIOCHEMISTRY; CARDIOPULMONARY BYPASS; FLUORESCENCE; HYPEROXIA; INFLAMMATION; MALE; NONHUMAN; OXYGEN THERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

RATTUS;

CARDIOPULMONARY BYPASS MODEL; CYTOKINE; HYPEROXIA; SUPEROXIDE; SYSTEMIC INFLAMMATION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; DISEASE MODELS, ANIMAL; HYPEROXIA; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; LUNG; MALE; OXIDATIVE STRESS; PULMONARY EDEMA; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; TIME FACTORS;

EID: 84890201596     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12125     Document Type: Article

References (23)

1. Walker G, Liddell M, Davis C. Extracorporeal life support-state of the art. Paediatr Respir Rev 2003;4:147-152.
2. Gao D, Grunwald GK, Rumsfeld JS, et al. Variation in mortality risk factors with time after coronary artery bypass graft operation. Ann Thorac Surg 2003;75:74-81.
3. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-559.
4. Engelman RM, Rousou JA, Flack JE 3rd, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 1995;60:801-804.
5. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1714-1720.
6. Fujii Y, Shirai M, Inamori S, et al. Insufflation of hydrogen gas restrains the inflammatory response of cardiopulmonary bypass in a rat model. Artif Organs 2013;37:136-141.
7. Kilgannon JH, Jones AE, Shapiro NI, et al.; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA 2010;303:2165-2171.
8. Lee PJ, Choi AM. Pathways of cell signaling in hyperoxia. Free Radic Biol Med 2003;35:341-350.
9. Morita K. Surgical reoxygenation injury of the myocardium in cyanotic patients: clinical relevance and therapeutic strategies by normoxic management during cardiopulmonary bypass. Gen Thorac Cardiovasc Surg 2012;60:549-556.
10. Pasquale MD, Cipolle MD, Monaco J, Simon N. Early inflammatory response correlates with the severity of injury. Crit Care Med 1996;24:1238-1242.
11. Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 2007;141:32-40.
12. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997;63:277-284.
13. Goudeau JJ, Clermont G, Guillery O, et al. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol 2007;49:39-45.
14. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 2002;96:80-87.
15. Jones CI 3rd, Han Z, Presley T, et al. Endothelial cell respiration is affected by the oxygen tension during shear exposure: role of mitochondrial peroxynitrite. Am J Physiol Cell Physiol 2008;295:180-191.
16. Pagano A, Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci 2003;1010:405-416.
17. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
18. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
19. Lee HS, Kim CK. Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia. Respir Res 2011;12:68.
20. Aebert H, Kirchner S, Keyser A, et al. Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 2000;18:589-593.
21. Kistler GS, Caldwell PR, Weibel ER. Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J Cell Biol 1967;32:605-628.
22. Zaher TE, Miller EJ, Morrow DM, Javdan M, Mantell LL. Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. Free Radic Biol Med 2007;42:897-908.
23. Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med 1983;309:878-883.